drug · small molecule
patient view →REC-4881
Phase 2updated 2mo agoby $RXRX RECURSION PHARMACEUTICALS, INC.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2, with 1 investigational indication.
targets
Dual specificity mitogen-activated protein kinase kinase 1Dual specificity mitogen-activated protein kinase kinase 2
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that